Captrust Financial Advisors Becton Dickinson & CO Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Becton Dickinson & CO stock. As of the latest transaction made, Captrust Financial Advisors holds 80,252 shares of BDX stock, worth $18.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

80,252

Previous 81,523 1.56%

Holding current value

$18.6 Million

Previous $20.2 Million 7.02%

% of portfolio

0.06%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $286,063 - $312,882	-1,271 Reduced 1.56%	80,252 $18.8 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $3.99 Million - $4.24 Million	-17,103 Reduced 17.34%	81,523 $20.2 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $647,020 - $744,502	-2,786 Reduced 2.75%	98,626 $24 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $89,469 - $99,540	351 Added 0.35%	101,412 $26.2 Million
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $3.79 Million - $4.22 Million	15,897 Added 18.67%	101,061 $26.7 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $1.58 Million - $1.79 Million	-6,899 Reduced 7.49%	85,164 $21.1 Million
Q4 2022 Feb 15, 2023	BUY	$218.29 - $256.91 $934,281 - $1.1 Million	4,280 Added 4.88%	92,063 $23.4 Million
Q3 2022 Nov 16, 2022	BUY	$51.03 - $264.23 $305,465 - $1.58 Million	5,986 Added 7.32%	87,783 $19.6 Million
Q2 2022 Aug 23, 2022	SELL	$234.74 - $275.42 $1.23 Million - $1.44 Million	-5,228 Reduced 6.01%	81,797 $20.2 Million
Q2 2022 Aug 16, 2022	BUY	$234.74 - $275.42 $4.08 Million - $4.79 Million	17,393 Added 24.98%	87,025 $21.5 Million
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $153,493 - $170,402	-630 Reduced 0.9%	69,632 $18.5 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $25,308 - $27,603	-110 Reduced 0.16%	70,262 $17.7 Million
Q3 2021 Nov 16, 2021	BUY	$232.72 - $256.47 $310,913 - $342,643	1,336 Added 1.94%	70,372 $17.3 Million
Q2 2021 Aug 16, 2021	BUY	$232.65 - $254.58 $81,194 - $88,848	349 Added 0.51%	69,036 $16.8 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $246,247 - $272,549	1,061 Added 1.57%	68,687 $16.7 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $679,297 - $752,822	3,061 Added 4.74%	67,626 $16.9 Million
Q3 2020 Nov 17, 2020	SELL	$215.77 - $276.76 $1.43 Million - $1.83 Million	-6,616 Reduced 9.29%	64,565 $14.9 Million
Q2 2020 Aug 14, 2020	SELL	$219.9 - $263.41 $397,139 - $475,718	-1,806 Reduced 2.47%	71,181 $17.2 Million
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $232,479 - $331,463	-1,188 Reduced 1.6%	72,987 $16.5 Million
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $2.8 Million - $3.16 Million	11,844 Added 19.0%	74,175 $20.2 Million
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $305,287 - $339,049	-1,324 Reduced 2.08%	62,331 $15.8 Million
Q2 2019 Aug 13, 2019	BUY	$217.4 - $246.08 $3.05 Million - $3.46 Million	14,051 Added 28.33%	63,655 $16 Million
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $96,843 - $116,639	-470 Reduced 0.94%	49,604 $12.4 Million
Q4 2018 Feb 13, 2019	SELL	$204.73 - $257.93 $98,884 - $124,580	-483 Reduced 0.96%	50,074 $11.3 Million
Q3 2018 Nov 15, 2018	BUY	$233.07 - $256.0 $3.83 Million - $4.21 Million	16,454 Added 48.25%	50,557 $13.2 Million
Q2 2018 Aug 13, 2018	BUY	$208.1 - $233.85 $839,891 - $943,818	4,036 Added 13.42%	34,103 $8.17 Million
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $413,180 - $483,182	-2,011 Reduced 6.27%	30,067 $6.41 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $6.06 Million - $7.14 Million	32,078	32,078 $6.87 Million

Others Institutions Holding BDX

# of Institutions

1,754

Shares Held

254M

Call Options Held

650K

Put Options Held

641K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Becton Dickinson & CO Transaction History